Ruxolitinib and Impurities
Ruxolitinib Impurity 25 (+)-Dibenzoyltartaric Acid Salt
CAS:1236033-04-7
Formula:
C23H32N6OSi·C18H14O8
Molecular weight:
436.64 358.30
Ref: 4Z-R-093040
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 26 Nov 2024
Ref: 4Z-R-093036
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 26 Nov 2024
Ref: 4Z-R-093033
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 26 Nov 2024
Ref: 4Z-R-093037
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 26 Nov 2024
Ref: 4Z-R-093023
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 26 Nov 2024
Ref: 4Z-R-093041
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 26 Nov 2024
Ref: 4Z-R-093048
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 26 Nov 2024
Ref: 4Z-R-093052
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 26 Nov 2024
Ref: 4Z-R-093051
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 26 Nov 2024
Ref: 4Z-R-093005
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 26 Nov 2024
Ref: 4Z-R-093032
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 26 Nov 2024
Ref: 4Z-R-093024
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 26 Nov 2024
Ref: 4Z-R-093062
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 26 Nov 2024
Ref: 4Z-R-093065
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 26 Nov 2024
Ref: 4Z-R-093066
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 26 Nov 2024
Ref: 4Z-R-093067
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 26 Nov 2024
Ref: 4Z-R-093068
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 26 Nov 2024
Ref: 4Z-R-093063
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 26 Nov 2024
Ruxolitinib (S enantiomer)
CAS:941685-37-6
Ruxolitinib S enantiomer (INCB18424) is the S-enantiomer of Ruxolitinib. Ruxolitinib is the first potent, selective …
Formula:
C17H18N6
Purity:
99.5% - 99.79%
Color and Shape:
Solid
Molecular weight:
306.36
Ref: TM-T6156
5mg | 63.00 € | ||
10mg | 74.00 € | ||
50mg | 113.00 € | ||
100mg | 151.00 € | ||
1mL*10mM (DMSO) | 64.00 € |
Estimated delivery in United States, on Tuesday 26 Nov 2024
Ref: 4Z-R-093060
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 26 Nov 2024